CLINICAL_TRIALS
trial_result
· 2021-05-24
Clinical Trial Update: Perfluorohexyloctane (NOV03) for the Treatment of Signs and Symptoms of Dry Eye Disease (DED) [Phase 2]
Summary
Phase 2 clinical trial of perfluorohexyloctane (NOV03) for dry eye disease has been completed and results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novaliq GmbH | Conditions: Dry Eye Disease (DED) | Phase 2 | Status: COMPLETED | Results posted: 2021-05-24